Skip to main content

HCW Biologics Inc.

corporate_fare Company Profile

HCW Biologics Inc.

HCWB·NASDAQ·Life Sciences·CIK 0001828673

HCW Biologics Inc. is a clinical-stage biopharmaceutical company focused on developing fusion immunotherapeutics to treat diseases linked to chronic inflammation. The company has created novel compounds intended to treat autoimmune disorders, other proinflammatory diseases, cancer, and senescence-associated dysplasia. HCW Biologics has also started commercializing certain proprietary compounds for use as reagents in producing immunotherapeutics for infectious diseases and cancer. The company's approach targets chronic inflammation, which is believed to contribute to many diseases. This inflammation results from persistent immune cell activation and the buildup of senescent cells, which are non-proliferative but metabolically active. While senescence is a normal physiological process involved in wound healing, tissue maintenance, regeneration, embryogenesis, fibrosis regulation, and tumor suppression, the accumulation of senescent cells with Senescence-Associated Phenotype (SASP) proinflammatory factors is implicated as a major source of chronic sterile inflammation leading to aging-related pathologies. SASP factors, including proinflammatory cytokines, chemokines, and proteinases, drive an inflammation cycle. Over time, various insults cause normal tissue cells to become senescent, releasing SASP factors that activate immune cells. Prolonged immune cell activation also releases highly proinflammatory cytokines, leading to chronic low-grade inflammation and perpetuating this cycle. Two of the company's proprietary molecules, HCW9201 and HCW9206, are ready for commercial use as reagents in immunotherapeutic treatments.

HCW Biologics Inc. (NASDAQ:HCWB) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 65 items for HCWB at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-18, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for HCWB spans PRE 14A, 10-Q, 8-K, S-1.

Recent high-impact activity:

  • HCW Biologics Re-Runs Warrant Approvals for 1.52M Shares After Quorum Failure
  • HCW Biologics 10-Q: $3.2M Q3 Loss, Two Unremediated Material Weaknesses, Going Concern Stands
  • HCW Biologics Q3 2026: Net Loss Narrows to $3.2M, Going Concern Warning Reiterated
  • HCW Biologics Posts $2.83 Per-Share Q3 Loss as Cash Crunch Deepens
  • HCW Biologics Raises Up to $10M in Secured Debt From Streeterville Capital

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$54.23K
Net Income
-$7.96M
Diluted EPS
-$10.63
Op. Cash Flow
-$13.39M
Free Cash Flow
-$13.39M
Gross Profit
$10.85K
Operating Income
-$13.16M
Cash & Equivalents
$1.95M
Total Debt
$6.81M
Debt / Equity
2.46×
Net Margin
-146.77×
Shares Outstanding
2.1M sh
Source: 10-K · filed 2026-03-31 · accession 0001193125-26-134934

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 49,290 shares in HCWB as of the October 30, 2026 settlement, a 30.7% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 15.7% of HCWB volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)49,290 shares as of October 30, 2026
Change vs prior period▲ 30.7%
Days to cover1.00 at avg daily volume of 57,290
Daily short volume (FINRA facilities)15.7% of 11,432 shares on November 20, 2026
5-day average short volume39.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Moderate risk

Filing-implied dilution signals for HCWB, detected from its recent SEC filings · based on capital-structure filings through 2026-09-24.

3 shelf registrationsreverse split

$1.5M Private Placement Priced · Warrant Structure Creates Dilution Overhang

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with H →
$0.7673 +4.38% today
52-week range · as of 2026-11-18 $0.7428 – $23.94
Market cap
$2.35M
Volume
23.6K (0.2× avg)
3-mo avg 116.5K
Live data · 2026-11-22 12:14 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed HCWB - Latest Insights

HCWB
Nov 18, 2026, 5:24 PM EST
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $0.7639
Real-time Price: $0.7673 info
Change: +$0.0034 (+0.45%) info
Market Cap: $2.352M info
HCWB
Nov 16, 2026, 8:30 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.780
Real-time Price: $0.7673 info
Change: -$0.0127 (-2%) info
Market Cap: $2.352M info
HCWB
Nov 16, 2026, 8:30 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.780
Real-time Price: $0.7673 info
Change: -$0.0127 (-2%) info
Market Cap: $2.352M info
HCWB
Nov 16, 2026, 8:15 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.780
Real-time Price: $0.7673 info
Change: -$0.0127 (-2%) info
Market Cap: $2.352M info
HCWB
Nov 05, 2026, 9:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.09
Real-time Price: $0.7673 info
Change: -$0.3227 (-30%) info
Market Cap: $2.352M info
HCWB
Nov 05, 2026, 8:45 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.16
Real-time Price: $0.7673 info
Change: -$0.3927 (-34%) info
Market Cap: $2.352M info
HCWB
Oct 02, 2026, 4:30 PM EDT
Filing Type: S-1
Importance Score:
8
Price at Filing: $1.68
Real-time Price: $0.7673 info
Change: -$0.9127 (-54%) info
Market Cap: $2.352M info
HCWB
Sep 24, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.65
Real-time Price: $0.7673 info
Change: -$0.8827 (-53%) info
Market Cap: $2.352M info
HCWB
Sep 24, 2026, 8:29 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.60
Real-time Price: $0.7673 info
Change: -$0.8327 (-52%) info
Market Cap: $2.352M info
HCWB
Sep 08, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.72
Real-time Price: $0.7673 info
Change: -$1.95 (-72%) info
Market Cap: $2.352M info
HCWB
Sep 08, 2026, 8:50 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.75
Real-time Price: $0.7673 info
Change: -$1.98 (-72%) info
Market Cap: $2.352M info
HCWB
Sep 04, 2026, 7:56 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $2.95
Real-time Price: $0.7673 info
Change: -$2.18 (-74%) info
Market Cap: $2.352M info
HCWB
Sep 02, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.55
Real-time Price: $0.7673 info
Change: -$2.78 (-78%) info
Market Cap: $2.352M info
HCWB
Aug 20, 2026, 2:58 PM EDT
Filing Type: S-1
Importance Score:
8
Price at Filing: $2.34
Real-time Price: $0.7673 info
Change: -$1.57 (-67%) info
Market Cap: $2.352M info
HCWB
Aug 14, 2026, 3:30 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $2.66
Real-time Price: $0.7673 info
Change: -$1.89 (-71%) info
Market Cap: $2.352M info
HCWB
Aug 14, 2026, 3:29 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $2.66
Real-time Price: $0.7673 info
Change: -$1.89 (-71%) info
Market Cap: $2.352M info
HCWB
Aug 14, 2026, 3:20 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.74
Real-time Price: $0.7673 info
Change: -$1.97 (-72%) info
Market Cap: $2.352M info
HCWB
Aug 14, 2026, 3:10 PM EDT
Filing Type: 10-Q/A
Importance Score:
8
Price at Filing: $2.70
Real-time Price: $0.7673 info
Change: -$1.93 (-72%) info
Market Cap: $2.352M info
HCWB
Aug 14, 2026, 3:00 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.07
Real-time Price: $0.7673 info
Change: -$2.30 (-75%) info
Market Cap: $2.352M info
HCWB
Jul 31, 2026, 4:10 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $3.20
Real-time Price: $0.7673 info
Change: -$2.43 (-76%) info
Market Cap: $2.352M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets